ART in women 40 and over. Is the cost worth it?
OBJECTIVE
To determine the efficacy and cost of assisted reproductive techniques in older women (40 years or older) in comparison to younger women (less than 30 years old).


METHODS
Retrospective review of records from one university-based infertility practice.


RESULTS
Women 40 years or older were significantly less likely to achieve pregnancy with human menopausal gonadotropin (hMG)/intrauterine insemination as compared to women under age 30. The older women were also significantly less likely to achieve pregnancy with in vitro fertilization (IVF). The use of donor oocytes resulted in the highest pregnancy rates in older women. Costs per cycle were similar, however, for both groups.


CONCLUSIONS
Older women will consume an equal amount of medical resources per cycle in infertility treatment as compared to younger women (aged < 30 years). However, older women utilizing assisted reproductive techniques are four to five times less likely to achieve pregnancy than the younger group. This poor prognosis for success in older women adds significantly to the mean cost per pregnancy as compared to younger women. Donor oocytes may be the most cost-effective option for achieving pregnancy in older women.
Legro
R S
RS
Department of Obstetrics and Gynecology, M.S. Hershey Medical Center, Hershey, PA 17033, USA.
Shackleford
D P
DP
Moessner
J M
JM
Gnatuk
C L
CL
Dodson
W C
WC
D000328:Adult; D000367:Age Factors; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D007315:Insemination, Artificial; D008596:Menotropins / Q000627:therapeutic use; D018587:Oocyte Donation / Q000191:economics; D011247:Pregnancy; D011379:Prognosis; D012099:Reproductive Techniques / Q000191:economics*; D012189:Retrospective Studies
D008596:Menotropins